Induced protection from a CCHFV-M DNA vaccine requires CD8+ T cells
Crimean-Congo hemorrhagic fever (CCHF) is a World Health Organization prioritized disease because its broad distribution and severity of disease make it a global health threat. Despite advancements in preclinical vaccine development for CCHF virus (CCHFV), including multiple platforms targeting mult...
Main Authors: | Joseph W. Golden, Collin J. Fitzpatrick, John J. Suschak, Tamara L. Clements, Keersten M. Ricks, Mariano Sanchez-Lockhart, Aura R. Garrison |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Virus Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0168170223001351 |
Similar Items
-
Seroepidemiology of Crimean-Congo Hemorrhagic Fever Virus (CCHFV) in Cattle across Three Livestock Pastoral Regions in Kenya
by: Isabel Blanco-Penedo, et al.
Published: (2021-08-01) -
Study of the Epidemiological Status of Crimean-Congo Hemorrhagic Fever Disease in Qom Province, 2011, Iran
by: Babak Farzinnia, et al.
Published: (2013-09-01) -
The CD8+T cells response is sufficient for protection with a CCHFV M-segment based DNA vaccine and GP38 enhances vaccine immunogenicity
by: Dr. Joseph Golden, et al.
Published: (2025-03-01) -
Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease
by: Aura R. Garrison, et al.
Published: (2019-06-01) -
Sheep and Cattle Are Not Susceptible to Experimental Inoculation with Hazara Orthonairovirus, a Tick-Borne Arbovirus Closely Related to CCHFV
by: Julia Hartlaub, et al.
Published: (2020-12-01)